In the TISIDB database, we further verified that MYEOV was associated with higher grade and shorter OS in pancreatic cancer, while there was no significant association with the higher stage (Figure 1D and Figure S1). This evidence concerns the gene MYEOV and familial pancreatic carcinoma.